Skip to main content

Drug Interactions between finerenone and landiolol

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

landiolol finerenone

Applies to: landiolol and finerenone

Consumer information for this interaction is not currently available.

MONITOR: Concomitant use of multiple other antihypertensive agents or drugs with hypotensive properties may potentiate the risk of hypotension during treatment with finerenone. In a phase 3 clinical study, hypotension was reported in 4.8% of patients treated with finerenone compared to 3.4% of patients receiving placebo. The majority of hypotension events in the finerenone group were mild or moderate and resolved. Finerenone treatment was permanently discontinued due to hypotension in one patient (<0.1%), while hospitalization due to hypotension was 0.2% in both the finerenone group and the placebo group. Mean systolic blood pressure decreased by 2 to 4 mmHg and mean diastolic blood pressure decreased by 1 to 2 mmHg with finerenone treatment at one month, but remained stable thereafter.

MANAGEMENT: Blood pressure should be monitored regularly in patients receiving finerenone with other antihypertensive agents. Patients should be advised to contact their physician if they experience symptoms of hypotension such as dizziness, lightheadedness, or fainting.

Drug and food interactions

Major

finerenone food

Applies to: finerenone

Finerenone may be taken with or without food. However, you should avoid grapefruit and grapefruit juice during treatment with this medication. Grapefruit juice may significantly increase the blood levels and effects of finerenone. This can increase the risk of developing hyperkalemia, or high levels of potassium in the blood, which in severe cases can lead to kidney failure, muscle paralysis, irregular heart rhythm, and cardiac arrest. You may be more likely to develop hyperkalemia during treatment with finerenone if you are elderly, dehydrated, or have kidney disease, diabetes, or advanced heart failure. You should also avoid potassium-containing salt substitutes or over-the-counter potassium supplements during treatment with finerenone unless otherwise directed by your doctor. Seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, as these may be symptoms of hyperkalemia. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.